nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—esophageal cancer	0.545	1	CbGaD
Nizatidine—BCHE—Cisplatin—esophageal cancer	0.194	0.705	CbGbCtD
Nizatidine—HRH2—gastric juice—esophageal cancer	0.0642	0.575	CbGeAlD
Nizatidine—ABCB1—Cisplatin—esophageal cancer	0.0493	0.179	CbGbCtD
Nizatidine—ABCB1—Methotrexate—esophageal cancer	0.032	0.116	CbGbCtD
Nizatidine—BCHE—diaphragm—esophageal cancer	0.0235	0.211	CbGeAlD
Nizatidine—HRH2—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—esophageal cancer	0.00902	0.256	CbGpPWpGaD
Nizatidine—HRH2—digestive system—esophageal cancer	0.00392	0.0351	CbGeAlD
Nizatidine—HRH2—lung—esophageal cancer	0.00327	0.0293	CbGeAlD
Nizatidine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00252	0.0717	CbGpPWpGaD
Nizatidine—Ranitidine—ABCB1—esophageal cancer	0.00251	1	CrCbGaD
Nizatidine—HRH2—lymph node—esophageal cancer	0.00224	0.02	CbGeAlD
Nizatidine—BCHE—bronchus—esophageal cancer	0.00221	0.0198	CbGeAlD
Nizatidine—BCHE—smooth muscle tissue—esophageal cancer	0.00216	0.0194	CbGeAlD
Nizatidine—BCHE—trachea—esophageal cancer	0.00199	0.0178	CbGeAlD
Nizatidine—BCHE—Irinotecan Pathway—ABCC2—esophageal cancer	0.0019	0.0539	CbGpPWpGaD
Nizatidine—BCHE—digestive system—esophageal cancer	0.00171	0.0153	CbGeAlD
Nizatidine—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00145	0.0411	CbGpPWpGaD
Nizatidine—BCHE—lung—esophageal cancer	0.00143	0.0128	CbGeAlD
Nizatidine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—esophageal cancer	0.00114	0.0325	CbGpPWpGaD
Nizatidine—ABCB1—epithelium—esophageal cancer	0.00107	0.00959	CbGeAlD
Nizatidine—BCHE—lymph node—esophageal cancer	0.000976	0.00874	CbGeAlD
Nizatidine—ABCB1—trachea—esophageal cancer	0.000946	0.00848	CbGeAlD
Nizatidine—Infection—Carboplatin—esophageal cancer	0.000911	0.0299	CcSEcCtD
Nizatidine—Liver injury—Cisplatin—esophageal cancer	0.000896	0.0294	CcSEcCtD
Nizatidine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000889	0.0252	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—ADCYAP1—esophageal cancer	0.000848	0.0241	CbGpPWpGaD
Nizatidine—ABCB1—digestive system—esophageal cancer	0.000814	0.00729	CbGeAlD
Nizatidine—Hyperuricaemia—Cisplatin—esophageal cancer	0.000813	0.0267	CcSEcCtD
Nizatidine—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000792	0.0225	CbGpPWpGaD
Nizatidine—Pain—Carboplatin—esophageal cancer	0.000784	0.0258	CcSEcCtD
Nizatidine—Blood uric acid increased—Cisplatin—esophageal cancer	0.000768	0.0252	CcSEcCtD
Nizatidine—Hepatocellular injury—Cisplatin—esophageal cancer	0.000754	0.0248	CcSEcCtD
Nizatidine—Body temperature increased—Carboplatin—esophageal cancer	0.000725	0.0238	CcSEcCtD
Nizatidine—ABCB1—lung—esophageal cancer	0.00068	0.00609	CbGeAlD
Nizatidine—Nasal congestion—Cisplatin—esophageal cancer	0.000601	0.0197	CcSEcCtD
Nizatidine—BCHE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.000591	0.0168	CbGpPWpGaD
Nizatidine—Irritability—Cisplatin—esophageal cancer	0.000522	0.0172	CcSEcCtD
Nizatidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000511	0.0145	CbGpPWpGaD
Nizatidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000511	0.0145	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—PDE4D—esophageal cancer	0.0005	0.0142	CbGpPWpGaD
Nizatidine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000489	0.0161	CcSEcCtD
Nizatidine—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000478	0.0136	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—GNG7—esophageal cancer	0.000475	0.0135	CbGpPWpGaD
Nizatidine—ABCB1—lymph node—esophageal cancer	0.000465	0.00417	CbGeAlD
Nizatidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000455	0.0129	CbGpPWpGaD
Nizatidine—Hyperuricaemia—Methotrexate—esophageal cancer	0.000446	0.0147	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000437	0.0144	CcSEcCtD
Nizatidine—Libido decreased—Capecitabine—esophageal cancer	0.000435	0.0143	CcSEcCtD
Nizatidine—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000435	0.0123	CbGpPWpGaD
Nizatidine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000428	0.014	CcSEcCtD
Nizatidine—Vasculitis—Methotrexate—esophageal cancer	0.000424	0.0139	CcSEcCtD
Nizatidine—Blood uric acid increased—Methotrexate—esophageal cancer	0.000421	0.0138	CcSEcCtD
Nizatidine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.0004	0.0131	CcSEcCtD
Nizatidine—Irritability—Capecitabine—esophageal cancer	0.000385	0.0126	CcSEcCtD
Nizatidine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000382	0.0108	CbGpPWpGaD
Nizatidine—Gynaecomastia—Methotrexate—esophageal cancer	0.00037	0.0122	CcSEcCtD
Nizatidine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000361	0.0119	CcSEcCtD
Nizatidine—Bronchospasm—Capecitabine—esophageal cancer	0.000343	0.0113	CcSEcCtD
Nizatidine—Flatulence—Cisplatin—esophageal cancer	0.000325	0.0107	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000318	0.0105	CcSEcCtD
Nizatidine—BCHE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000316	0.00897	CbGpPWpGaD
Nizatidine—Pneumonia—Capecitabine—esophageal cancer	0.000313	0.0103	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—ADCYAP1—esophageal cancer	0.000308	0.00874	CbGpPWpGaD
Nizatidine—Anaemia—Cisplatin—esophageal cancer	0.000305	0.01	CcSEcCtD
Nizatidine—Jaundice—Capecitabine—esophageal cancer	0.000303	0.00995	CcSEcCtD
Nizatidine—Irritability—Methotrexate—esophageal cancer	0.000287	0.00942	CcSEcCtD
Nizatidine—Convulsion—Cisplatin—esophageal cancer	0.000286	0.00938	CcSEcCtD
Nizatidine—Myalgia—Cisplatin—esophageal cancer	0.000281	0.00922	CcSEcCtD
Nizatidine—Rhinitis—Capecitabine—esophageal cancer	0.00028	0.00919	CcSEcCtD
Nizatidine—Anxiety—Cisplatin—esophageal cancer	0.00028	0.00919	CcSEcCtD
Nizatidine—Hepatitis—Capecitabine—esophageal cancer	0.000279	0.00917	CcSEcCtD
Nizatidine—Pharyngitis—Capecitabine—esophageal cancer	0.000277	0.0091	CcSEcCtD
Nizatidine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000269	0.00884	CcSEcCtD
Nizatidine—Infection—Cisplatin—esophageal cancer	0.000267	0.00878	CcSEcCtD
Nizatidine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000263	0.00865	CcSEcCtD
Nizatidine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00026	0.00854	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—esophageal cancer	0.000257	0.00844	CcSEcCtD
Nizatidine—Anorexia—Cisplatin—esophageal cancer	0.000256	0.00842	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000245	0.00805	CcSEcCtD
Nizatidine—Flatulence—Capecitabine—esophageal cancer	0.000239	0.00786	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000239	0.00785	CcSEcCtD
Nizatidine—Back pain—Capecitabine—esophageal cancer	0.000235	0.00772	CcSEcCtD
Nizatidine—Decreased appetite—Cisplatin—esophageal cancer	0.000234	0.00768	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—esophageal cancer	0.000233	0.00765	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000232	0.00763	CcSEcCtD
Nizatidine—Pain—Cisplatin—esophageal cancer	0.00023	0.00756	CcSEcCtD
Nizatidine—Anaemia—Capecitabine—esophageal cancer	0.000225	0.00738	CcSEcCtD
Nizatidine—Sweating—Methotrexate—esophageal cancer	0.000222	0.00729	CcSEcCtD
Nizatidine—Feeling abnormal—Cisplatin—esophageal cancer	0.000222	0.00728	CcSEcCtD
Nizatidine—Body temperature increased—Cisplatin—esophageal cancer	0.000213	0.00699	CcSEcCtD
Nizatidine—Cough—Capecitabine—esophageal cancer	0.000212	0.00696	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—esophageal cancer	0.000208	0.00682	CcSEcCtD
Nizatidine—Chest pain—Capecitabine—esophageal cancer	0.000207	0.00679	CcSEcCtD
Nizatidine—Myalgia—Capecitabine—esophageal cancer	0.000207	0.00679	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—esophageal cancer	0.000206	0.00677	CcSEcCtD
Nizatidine—Anxiety—Capecitabine—esophageal cancer	0.000206	0.00677	CcSEcCtD
Nizatidine—BCHE—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000205	0.00582	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000203	0.00576	CbGpPWpGaD
Nizatidine—Dry mouth—Capecitabine—esophageal cancer	0.000202	0.00665	CcSEcCtD
Nizatidine—Confusional state—Capecitabine—esophageal cancer	0.0002	0.00657	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.0002	0.00567	CbGpPWpGaD
Nizatidine—Infection—Capecitabine—esophageal cancer	0.000197	0.00647	CcSEcCtD
Nizatidine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000194	0.00638	CcSEcCtD
Nizatidine—Asthenia—Cisplatin—esophageal cancer	0.000193	0.00634	CcSEcCtD
Nizatidine—BCHE—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000192	0.00546	CbGpPWpGaD
Nizatidine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000192	0.0063	CcSEcCtD
Nizatidine—Anorexia—Capecitabine—esophageal cancer	0.000189	0.00621	CcSEcCtD
Nizatidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000186	0.00529	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000186	0.00527	CbGpPWpGaD
Nizatidine—Diarrhoea—Cisplatin—esophageal cancer	0.000184	0.00605	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000181	0.00593	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000181	0.00513	CbGpPWpGaD
Nizatidine—Insomnia—Capecitabine—esophageal cancer	0.000179	0.00589	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000176	0.005	CbGpPWpGaD
Nizatidine—Back pain—Methotrexate—esophageal cancer	0.000175	0.00575	CcSEcCtD
Nizatidine—Dyspepsia—Capecitabine—esophageal cancer	0.000175	0.00573	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000174	0.00494	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—GNG7—esophageal cancer	0.000173	0.0049	CbGpPWpGaD
Nizatidine—Decreased appetite—Capecitabine—esophageal cancer	0.000172	0.00566	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000171	0.00562	CcSEcCtD
Nizatidine—Vomiting—Cisplatin—esophageal cancer	0.000171	0.00562	CcSEcCtD
Nizatidine—Rash—Cisplatin—esophageal cancer	0.00017	0.00557	CcSEcCtD
Nizatidine—Constipation—Capecitabine—esophageal cancer	0.00017	0.00557	CcSEcCtD
Nizatidine—Pain—Capecitabine—esophageal cancer	0.00017	0.00557	CcSEcCtD
Nizatidine—Dermatitis—Cisplatin—esophageal cancer	0.000169	0.00557	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—esophageal cancer	0.000167	0.00549	CcSEcCtD
Nizatidine—Feeling abnormal—Capecitabine—esophageal cancer	0.000163	0.00537	CcSEcCtD
Nizatidine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000162	0.00533	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000161	0.00458	CbGpPWpGaD
Nizatidine—Nausea—Cisplatin—esophageal cancer	0.00016	0.00525	CcSEcCtD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000158	0.0045	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000158	0.00449	CbGpPWpGaD
Nizatidine—Cough—Methotrexate—esophageal cancer	0.000158	0.00518	CcSEcCtD
Nizatidine—Urticaria—Capecitabine—esophageal cancer	0.000158	0.00517	CcSEcCtD
Nizatidine—BCHE—Neuronal System—GNG7—esophageal cancer	0.000157	0.00446	CbGpPWpGaD
Nizatidine—Abdominal pain—Capecitabine—esophageal cancer	0.000157	0.00515	CcSEcCtD
Nizatidine—Body temperature increased—Capecitabine—esophageal cancer	0.000157	0.00515	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—esophageal cancer	0.000157	0.00515	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—esophageal cancer	0.000154	0.00506	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—esophageal cancer	0.000154	0.00506	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CXCL2—esophageal cancer	0.000152	0.00432	CbGpPWpGaD
Nizatidine—Confusional state—Methotrexate—esophageal cancer	0.000149	0.00489	CcSEcCtD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000148	0.0042	CbGpPWpGaD
Nizatidine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000148	0.00485	CcSEcCtD
Nizatidine—BCHE—Neuronal System—ALDH2—esophageal cancer	0.000147	0.00418	CbGpPWpGaD
Nizatidine—Infection—Methotrexate—esophageal cancer	0.000147	0.00482	CcSEcCtD
Nizatidine—HRH2—Signaling Pathways—GDI2—esophageal cancer	0.000145	0.00411	CbGpPWpGaD
Nizatidine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000145	0.00475	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000143	0.00469	CcSEcCtD
Nizatidine—Asthenia—Capecitabine—esophageal cancer	0.000142	0.00467	CcSEcCtD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000142	0.00403	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—ANXA1—esophageal cancer	0.000141	0.00401	CbGpPWpGaD
Nizatidine—Anorexia—Methotrexate—esophageal cancer	0.000141	0.00462	CcSEcCtD
Nizatidine—Pruritus—Capecitabine—esophageal cancer	0.00014	0.00461	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—SST—esophageal cancer	0.000137	0.00391	CbGpPWpGaD
Nizatidine—Diarrhoea—Capecitabine—esophageal cancer	0.000136	0.00446	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000134	0.00442	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—GHRL—esophageal cancer	0.000134	0.00381	CbGpPWpGaD
Nizatidine—Insomnia—Methotrexate—esophageal cancer	0.000134	0.00439	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—esophageal cancer	0.000131	0.00431	CcSEcCtD
Nizatidine—Dizziness—Capecitabine—esophageal cancer	0.000131	0.00431	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—esophageal cancer	0.00013	0.00427	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—esophageal cancer	0.000128	0.00422	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000127	0.00419	CcSEcCtD
Nizatidine—Pain—Methotrexate—esophageal cancer	0.000126	0.00415	CcSEcCtD
Nizatidine—Vomiting—Capecitabine—esophageal cancer	0.000126	0.00414	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000125	0.00355	CbGpPWpGaD
Nizatidine—Rash—Capecitabine—esophageal cancer	0.000125	0.00411	CcSEcCtD
Nizatidine—Dermatitis—Capecitabine—esophageal cancer	0.000125	0.0041	CcSEcCtD
Nizatidine—Headache—Capecitabine—esophageal cancer	0.000124	0.00408	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—esophageal cancer	0.000122	0.004	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000121	0.00396	CcSEcCtD
Nizatidine—Nausea—Capecitabine—esophageal cancer	0.000118	0.00387	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—esophageal cancer	0.000117	0.00385	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—esophageal cancer	0.000117	0.00383	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—esophageal cancer	0.000117	0.00383	CcSEcCtD
Nizatidine—BCHE—Metabolism of proteins—XBP1—esophageal cancer	0.000116	0.00331	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000116	0.0033	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000112	0.00318	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000112	0.00317	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000107	0.00304	CbGpPWpGaD
Nizatidine—Asthenia—Methotrexate—esophageal cancer	0.000106	0.00348	CcSEcCtD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000106	0.003	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KMT2D—esophageal cancer	0.000105	0.00297	CbGpPWpGaD
Nizatidine—Pruritus—Methotrexate—esophageal cancer	0.000104	0.00343	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000103	0.00291	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AKAP13—esophageal cancer	0.000102	0.00289	CbGpPWpGaD
Nizatidine—Diarrhoea—Methotrexate—esophageal cancer	0.000101	0.00332	CcSEcCtD
Nizatidine—BCHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000101	0.00285	CbGpPWpGaD
Nizatidine—Dizziness—Methotrexate—esophageal cancer	9.76e-05	0.00321	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—GNG7—esophageal cancer	9.75e-05	0.00277	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	9.49e-05	0.0027	CbGpPWpGaD
Nizatidine—Vomiting—Methotrexate—esophageal cancer	9.39e-05	0.00308	CcSEcCtD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.34e-05	0.00265	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ADCYAP1—esophageal cancer	9.33e-05	0.00265	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PDE4D—esophageal cancer	9.31e-05	0.00264	CbGpPWpGaD
Nizatidine—Rash—Methotrexate—esophageal cancer	9.31e-05	0.00306	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—esophageal cancer	9.3e-05	0.00305	CcSEcCtD
Nizatidine—Headache—Methotrexate—esophageal cancer	9.25e-05	0.00304	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—GNG7—esophageal cancer	8.86e-05	0.00252	CbGpPWpGaD
Nizatidine—Nausea—Methotrexate—esophageal cancer	8.77e-05	0.00288	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—CXCL2—esophageal cancer	8.59e-05	0.00244	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—WWOX—esophageal cancer	8.54e-05	0.00242	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	8.5e-05	0.00241	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—BLVRB—esophageal cancer	8.3e-05	0.00236	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SLC52A3—esophageal cancer	8.3e-05	0.00236	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	8.26e-05	0.00235	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FKBP1A—esophageal cancer	8.12e-05	0.00231	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—ANXA1—esophageal cancer	7.99e-05	0.00227	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—WIF1—esophageal cancer	7.94e-05	0.00225	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CXCL2—esophageal cancer	7.8e-05	0.00222	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	7.78e-05	0.00221	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—SST—esophageal cancer	7.77e-05	0.00221	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—GHRL—esophageal cancer	7.57e-05	0.00215	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.42e-05	0.00211	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	7.4e-05	0.0021	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.35e-05	0.00209	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CSNK1A1—esophageal cancer	7.32e-05	0.00208	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—ANXA1—esophageal cancer	7.25e-05	0.00206	CbGpPWpGaD
Nizatidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	7.15e-05	0.00203	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CA1—esophageal cancer	7.06e-05	0.002	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SLC10A2—esophageal cancer	7.06e-05	0.002	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—SST—esophageal cancer	7.06e-05	0.002	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—ACTB—esophageal cancer	6.92e-05	0.00197	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	6.91e-05	0.00196	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GHRL—esophageal cancer	6.88e-05	0.00195	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PFN1—esophageal cancer	6.85e-05	0.00195	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.55e-05	0.00186	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	6.47e-05	0.00184	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CA2—esophageal cancer	6.46e-05	0.00183	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.31e-05	0.00179	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	6.27e-05	0.00178	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—HSPA5—esophageal cancer	6.26e-05	0.00178	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.25e-05	0.00178	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ELMO1—esophageal cancer	6.15e-05	0.00175	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.07e-05	0.00172	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CALR—esophageal cancer	6.06e-05	0.00172	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AKAP13—esophageal cancer	6.01e-05	0.00171	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PLCE1—esophageal cancer	6e-05	0.0017	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ADH7—esophageal cancer	6e-05	0.0017	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	5.99e-05	0.0017	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	5.99e-05	0.0017	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—GHRL—esophageal cancer	5.96e-05	0.00169	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.93e-05	0.00168	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—FBXW7—esophageal cancer	5.86e-05	0.00167	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	5.74e-05	0.00163	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HIST1H2BM—esophageal cancer	5.55e-05	0.00158	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PDE4D—esophageal cancer	5.5e-05	0.00156	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	5.43e-05	0.00154	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ADH1B—esophageal cancer	5.26e-05	0.00149	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GNG7—esophageal cancer	5.23e-05	0.00149	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TYMP—esophageal cancer	5.03e-05	0.00143	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—XIAP—esophageal cancer	4.9e-05	0.00139	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP26A1—esophageal cancer	4.89e-05	0.00139	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALOX15—esophageal cancer	4.77e-05	0.00135	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CTNNA1—esophageal cancer	4.64e-05	0.00132	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCL2—esophageal cancer	4.61e-05	0.00131	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GSTO1—esophageal cancer	4.55e-05	0.00129	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TPI1—esophageal cancer	4.55e-05	0.00129	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.54e-05	0.00129	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALDOB—esophageal cancer	4.36e-05	0.00124	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PSME2—esophageal cancer	4.31e-05	0.00122	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PSME1—esophageal cancer	4.31e-05	0.00122	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ANXA1—esophageal cancer	4.28e-05	0.00122	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GAPDH—esophageal cancer	4.2e-05	0.00119	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SST—esophageal cancer	4.17e-05	0.00118	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CRABP1—esophageal cancer	4.16e-05	0.00118	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.12e-05	0.00117	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.08e-05	0.00116	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GHRL—esophageal cancer	4.06e-05	0.00115	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH3—esophageal cancer	4.06e-05	0.00115	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.06e-05	0.00115	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—BLVRB—esophageal cancer	4.05e-05	0.00115	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.05e-05	0.00115	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FBXW7—esophageal cancer	4e-05	0.00114	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GNG7—esophageal cancer	3.96e-05	0.00112	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALDH2—esophageal cancer	3.71e-05	0.00105	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH2—esophageal cancer	3.64e-05	0.00103	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GSTT1—esophageal cancer	3.53e-05	0.001	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.5e-05	0.000993	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP2A6—esophageal cancer	3.49e-05	0.00099	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.47e-05	0.000986	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CA1—esophageal cancer	3.44e-05	0.000978	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.44e-05	0.000978	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.4e-05	0.000965	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.32e-05	0.000944	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTGS1—esophageal cancer	3.3e-05	0.000939	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ENO1—esophageal cancer	3.3e-05	0.000939	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PSME2—esophageal cancer	3.26e-05	0.000925	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PSME1—esophageal cancer	3.26e-05	0.000925	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TGFBR2—esophageal cancer	3.23e-05	0.000918	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CA2—esophageal cancer	3.15e-05	0.000895	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SMAD4—esophageal cancer	3.06e-05	0.000869	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3e-05	0.000853	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ADH7—esophageal cancer	2.93e-05	0.000832	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLCE1—esophageal cancer	2.93e-05	0.000832	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.9e-05	0.000825	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.84e-05	0.000808	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP1B1—esophageal cancer	2.81e-05	0.000798	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.76e-05	0.000785	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP19A1—esophageal cancer	2.64e-05	0.00075	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ADH1B—esophageal cancer	2.57e-05	0.000729	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.51e-05	0.000713	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HIF1A—esophageal cancer	2.5e-05	0.000711	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TYMP—esophageal cancer	2.45e-05	0.000697	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—HMOX1—esophageal cancer	2.41e-05	0.000685	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.41e-05	0.000684	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KDR—esophageal cancer	2.39e-05	0.00068	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.39e-05	0.000678	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.36e-05	0.000672	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.36e-05	0.000669	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.33e-05	0.000661	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCB1—esophageal cancer	2.31e-05	0.000657	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH1—esophageal cancer	2.26e-05	0.000641	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TPI1—esophageal cancer	2.22e-05	0.00063	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GSTO1—esophageal cancer	2.22e-05	0.00063	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALDOB—esophageal cancer	2.13e-05	0.000604	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GAPDH—esophageal cancer	2.05e-05	0.000582	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CREBBP—esophageal cancer	2.04e-05	0.000581	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.04e-05	0.000581	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CRABP1—esophageal cancer	2.03e-05	0.000576	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EGFR—esophageal cancer	2.01e-05	0.000571	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.98e-05	0.000562	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GNG7—esophageal cancer	1.93e-05	0.000548	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.92e-05	0.000545	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOS3—esophageal cancer	1.83e-05	0.00052	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALDH2—esophageal cancer	1.81e-05	0.000514	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.75e-05	0.000497	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CA—esophageal cancer	1.74e-05	0.000495	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GSTT1—esophageal cancer	1.72e-05	0.000489	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ERBB2—esophageal cancer	1.71e-05	0.000486	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.7e-05	0.000483	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.61e-05	0.000458	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ENO1—esophageal cancer	1.61e-05	0.000458	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.61e-05	0.000458	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PSME2—esophageal cancer	1.59e-05	0.000451	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PSME1—esophageal cancer	1.59e-05	0.000451	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CREBBP—esophageal cancer	1.55e-05	0.000439	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCND1—esophageal cancer	1.51e-05	0.00043	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CDKN1A—esophageal cancer	1.46e-05	0.000416	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EP300—esophageal cancer	1.39e-05	0.000396	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—NOS3—esophageal cancer	1.38e-05	0.000393	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.37e-05	0.000389	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.29e-05	0.000366	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTGS2—esophageal cancer	1.27e-05	0.00036	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MYC—esophageal cancer	1.21e-05	0.000345	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EGFR—esophageal cancer	1.19e-05	0.000337	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.18e-05	0.000334	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—EP300—esophageal cancer	1.05e-05	0.000299	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CA—esophageal cancer	1.03e-05	0.000293	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TP53—esophageal cancer	9.97e-06	0.000283	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CA—esophageal cancer	7.79e-06	0.000221	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CREBBP—esophageal cancer	7.55e-06	0.000214	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—NOS3—esophageal cancer	6.76e-06	0.000192	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTGS2—esophageal cancer	6.18e-06	0.000175	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—EP300—esophageal cancer	5.14e-06	0.000146	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.8e-06	0.000108	CbGpPWpGaD
